Just like the novel coronavirus itself, the emergence of so-called long COVID has surprised both the patients who couldn’t shake their symptoms and the clinicians who have struggled to provide effective treatments. Now, as the U.S. looks to move past the pandemic, there remain unanswered questions about how this fallout from the virus might hamper some workers and for how long. These uncertainties could have important implications for workers’ compensation. By some measures, one in four patients who get COVID-19—even those with mild or asymptomatic cases—will experience subsequent symptoms that range from muscle and nerve pain to breathing difficulties to anxiety and depression. The scope of the challenge will require providers and employers to better understand the nature of the conditions, their origins, and the best paths for treatment. Watch this on-demand webinar to learn more about long COVID and the implications for workers and employers.
More stories
From Hospital to Home and All Points in Between: The Importance of Transition of Care Planning in Driving The Best Possible Outcomes
Discover the transformative power of transition of care planning for your toughest claims in our latest white paper, From Hospital to Home and All Points In Between: The Importance of Transition of Care Planning.
Six Legislative and Regulatory Changes and Trends Impacting the Insurance Industry
Explore the critical legislative and regulatory changes impacting the insurance industry in 2024. Stay informed on AAPAN's role, CMS updates, and trends in auto and workers' compensation.
Enlyte Lobbying Outlooks for 2024
At Enlyte, our team of experts are continually monitoring emerging trends, keeping abreast with legislation and case law, and lobbying to help shape these complexities today and into tomorrow for the benefit of our customers and the industry.
Specialty Solutions Spotlight: Cybersecurity Risks With Internet Connected Medical Devices
The advent of the Internet of Medical Things (IoMT) has facilitated the transmission of data from medical devices and enabled physicians to remotely customize treatment settings. However, like other computer systems, medical devices are susceptible to security breaches, which have the potential to compromise the device’s safety and effectiveness.
Ask The Pharmacist: Fixed-Dose Combination Drugs in Workers’ Comp
Fixed-dose combination drug products (FDCDPs) are made up of two different drug ingredients in a single formulation, containing a fixed amount of each. Among the more recognizable examples of these are Symbicort (budesonide-formoterol), Suboxone (buprenorphine-naloxone), Treximet (sumatriptan-naproxen), and Tylenol PM (acetaminophen-diphenhydramine). Several FDCDPs for pain management also exist such as Vimovo (naproxen-esomeprazole), Duexis (ibuprofen-famotidine), and Seglentis (celecoxib-tramadol).
Enlyte’s 2024 Trends Report Addresses Top Challenges in the P&C Industry
As the Property and Casualty industry sets course for 2024, executives face continuing challenges in integrating generative AI, understanding data analytics maturity, staying current with prescription drug trends, and managing medical and auto claims costs amidst fears of inflation and legislative and regulatory changes.